Health
Genomics is helping us tackle the greatest health challenges of our time, driving life-saving breakthroughs and unlocking revolutionary advances in personalized medicine.
Fueled by more than two decades of investment by Genome Canada, genomics-enabled precision health tools are speeding up diagnoses and improving health outcomes and disease management for Canadians. Genomics is also playing a leading role in Canada’s response to major public health challenges, such as COVID-19—permitting vaccine development at record speed and large-scale sequencing efforts to track and understand the pandemic.
Genome Canada is charting a bold and more equitable future for healthcare in Canada as we harness the power of genomics—and create shared tools and data assets—to strengthen public health and shift from a disease-oriented healthcare system to one that is more precise, personalized, predictive, preventative and cost effective. We are also advancing a “One Health” approach (addressing the interconnectedness of people, animals, plants and their shared environment) to strengthen Canadian, and global, health security.
Genomics initiatives in health
All for One
A Pan-Canadian dialogue on the status of population cohorts in Canada
A national approach to large-scale, inclusive datasets can enable precision health to improve health outcomes and systems—driving life sciences innovation in Canada.
Generating solutions for Canada
Playlist
Genomics and the human health sector
The Promise of Precision Health: Sienna’s Story
“A family curse” warded off by Canadian genomics research
Coronavirus: Canada’s Research and Response | Dr. Rob Annan
Featuring Dr. Rob Annan, President and CEO, Genome Canada. In partnership with The Future Economy and part of a six-part series called The COVID-19 Rebound. (March 23, 2020)COVID-19 Point-of-Care Testing & Canada’s Ongoing Research Priorities
Featuring Dr. Dylan Pillai, Professor of Pathology and Laboratory Medicine, Medicine, and Microbiology, Immunology & Infectious Diseases at the University of Calgary, and funded through Genome Alberta. In partnership with The Future Economy and part of a six-part series called The COVID-19 Rebound. (April 20, 2020)
COVID-19 Research: Genomics, Collaboration and Funding
Featuring Dr. Natalie Prystajecky, Program Head, Environmental Microbiology & Molecular and Microbial Genomics Programs – BC Centre for Disease Control, and funded through Genome British Columbia. In partnership with The Future Economy and part of a six-part series called The COVID-19 Rebound. (April 21, 2020)
COVID-19 Research: Genomics, Rapid Execution & Funding
Featuring Dr. Samira Mubareka, Professor & Expert in Medical Microbiology and Infectious Diseases, and funded through Ontario Genomics. In partnership with The Future Economy and part of a six-part series called The COVID-19 Rebound. (April 27, 2020)COVID-19 Research: Vaccines, Genomics & Open Science
Featuring Dr. Aled Edwards, Chief Executive, Structural Genomics Consortium, and funded through Ontario Genomics and Genome Quebec. In partnership with The Future Economy and part of a six-part series called The COVID-19 Rebound. (April 28, 2020)
Canadian COVID-19 Vaccine Research Update
Covid-19 Rebound Series on how Canada’s economy is faring suring the crisis. This time we asked Dr. Volker Gerdts about Canadian vaccine research, why we should be aiming for self-sufficiency and how vaccines are being developed so much quicker than usual. The COVID-19 Rebound. (June 15, 2020)
